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Background: Flu vaccination is recommended annually for high risk groups. However, in Ireland, free access to
vaccination is not universal for those in high risk groups; the vaccine and consultation are only free for those with a
medical card, a means tested scheme. Few private health insurance policies cover the cost of attendance for
vaccination in general practice. The aim was to examine the influence of this reimbursement policy on vaccination
coverage among older adults.
Methods: Cross-sectional wave 1 data from The Irish Longitudinal Study on Ageing (TILDA) were analysed (2009–2011).
TILDA is a nationally representative prospective cohort study of adults aged ≥50, sampled using multistage stratified
clustered sampling. Self-reported entitlement to healthcare was categorised as 1) medical card only 2) private health
insurance only, 3) both and 4) neither. The outcome was responses to ‘have you ever had a flu shot’. Multivariate logistic
regression was used, adjusting for age and need.
Results: 68.6% of those defined as clinically high-risk received the flu vaccination in the past (95% CI = 67-71%). Those
with a medical card were almost twice as likely to have been vaccinated, controlling for age and chronic illness
(OR = 1.9, 95% CI = 1.5-2.5, p = <0.001).
Conclusions: Having a medical card increased the likelihood of being vaccinated, independent of age and need.
The mismatch between vaccination guidelines and reimbursement policy is creating unequal access to
recommended services among high risk groups.
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Seasonal influenza (flu) vaccination is a cornerstone of
preventive health care. Older people and those with cer-
tain chronic conditions are considered a ‘high risk’ group
as they are at increased risk of severe illness, hospitalisa-
tion or death if infected with influenza [1]. While there
is some debate about the efficacy of the influenza vaccin-
ation, it continues to be a key strategy for reducing flu-
related morbidity and mortality [2,3].
Achieving complete flu vaccination coverage in high
risk groups remains a challenge for many countries [4].
A UK study found that only 61% of those in high risk* Correspondence: s.mchugh@ucc.ie
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unless otherwise stated.clinical groups had received the vaccine in 2009/10 [5].
There is substantial variation in uptake rates between
countries [6,7]. The Survey on Health Ageing and Re-
tirement in Europe (SHARE) found that vaccination
rates among those aged 60 years and over ranged from
11% in Poland to 62% in the Netherlands [7]. The age-
standardised average uptake rate was 41%. Results from
the first wave of The Irish Longitudinal Study on Ageing
(TILDA) indicate that 50% of those aged 50 years and
over have received the flu vaccination in the past [8].
The Council of the European Union has set a target of
75% vaccination coverage for at-risk groups by 2015 [9].
As in most other developed countries [10,11], in
Ireland annual flu vaccination is recommended for older
people (≥65 years), and those with underlying health
conditions including chronic respiratory disease, chronicral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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addition, groups such as carers and those considered
morbidly obese (≥40 kg/m2) are recommended to re-
ceive the vaccine in Ireland [12]. The vaccine is adminis-
tered in a primary care setting by a General Practitioner
(GP), by a practice nurse or, since 2011, in community
pharmacies.
Age and clinical need are well-established in the litera-
ture as significant predictors of vaccination coverage
[6,7,13-15]. Less attention has been paid to the role of
socio-economic factors, but there is evidence suggesting
that factors such as income can have a significant impact
on flu vaccination rates [4], and that the direction of this
effect varies among countries [6]. Countries differ in
their approach to the financing of and reimbursement
for flu vaccination [11].
In Ireland, reimbursement for flu vaccination is lim-
ited, covering some but not all of the high risk groups
recommended for vaccination. The vaccine and consult-
ation are free for those (within recommended groups)
who hold a medical card. Having a medical card entitles
the holder to free access to primary and community care
services and exemption from co-payments in public hos-
pitals. Medical card eligibility is primarily based on in-
come; to qualify an individual’s weekly income must be
below a certain threshold. Approximately 37% of the
population have a medical card [16], rising to 90% of
those aged 70 years and older [8]. Persons within recom-
mended groups who do not have a medical card must
pay a consultation fee for the administration of the vac-
cine although the vaccine itself is free. The consultation
fee ranges from €35 to €70 euro, with an average cost of
€51 euro [17]. Some practices offer reduced rates for ser-
vices such as flu vaccination.
Approximately 53% of those aged 50 years and over in
Ireland have private health insurance [8], however few
insurance policies cover the cost of GP attendance and a
limited number offer reduced fees for vaccinations at
private clinics. In Ireland, private health insurance is vol-
untary and duplicative, that is, it covers services already
provided by the public health system but also provides
access to other providers (e.g. private hospitals) or to dif-
ferent levels of service (e.g. faster access) [18]. Data from
Ireland provide a unique opportunity to investigate the
impact of reimbursement policy on vaccination cover-
age. The aim of this study was to examine the influence
of partial reimbursement on flu vaccination uptake
among older adults, controlling for the impact of age
and clinical need.
Methods
Study design and population
Our study is based on 8175 adults aged 50 years and
over from wave 1 of The Irish Longitudinal Study onAgeing (TILDA). TILDA is a prospective cohort study
conducted with a nationally representative sample of
non-institutionalized adults in the Republic of Ireland.
Multistage stratified clustered sampling was conducted
using the Geodirectory, a list of all the residential ad-
dresses in the Republic of Ireland, as the sampling
frame. A response rate of 62% was achieved based on
the proportion of eligible households from which an
interview was successfully obtained (6,279 households).
The design and methodology are described in detail else-
where [19,20]. Ethical approval was obtained from Trinity
College Dublin Research Ethics Committee and written
informed consent was obtained from participants.
Data were collected between October 2009 and February
2011 using three methods: computer-assisted personal inter-
viewing (CAPI) including questions on socio-demographics,
physical and mental health, employment/retirement, and
health service use; a Self-Completed Questionnaire (SCQ)
containing questions on quality of life, alcohol, anxiety, so-
cial connectedness and perceptions of ageing; and a detailed
health assessment.
Measures
The outcome was whether participants had ever received
the flu vaccination in the past. In wave 1 of TILDA, the
survey question was ‘have you ever received a flu shot’.
The independent variable of interest was entitlement to
health care categorised as: those with a medical card
only, those with private health insurance only, those with
both a medical card and private health insurance (de-
fined as dual cover) and those with neither (defined as
‘no additional cover’).
Statistical analysis
Vaccination coverage was calculated based on the per-
centage of individuals that reported ever having received
a flu vaccination. We examined coverage among those
in the ‘total high risk group’ recommended for vaccin-
ation according to guidelines from the Royal College of
Physicians [12]: those aged ≥65 years, those with a long-
term condition requiring follow-up (chronic lung dis-
ease, asthma, chronic heart disease, diabetes, liver dis-
ease, Parkinson’s disease, stroke/TIA), those classified as
morbidly obese (≥40 kg/m2) and those in receipt of
state-provided carers’ allowance. We compared this to
coverage among those in the ‘clinical risk group’ only, that
is those with a long-term condition requiring follow-up
(chronic lung disease, asthma, chronic heart disease, dia-
betes, liver disease, Parkinson’s disease, stroke/TIA).
Multivariate logistic regression was used to assess the
independent influence of entitlement to health services
on vaccination uptake adjusting for age, gender, income,
education, employment, self-rated health and clinical
need. Covariates were selected a priori based on
Mc Hugh et al. BMC Public Health  (2015) 15:83 Page 3 of 7Andersen’s model of health service utilisation which cat-
egorises determinants as predisposing (age, sex), enab-
ling (education, income, employment) and need factors
(clinical need and self-rated health) [21]. These factors
have also been linked to entitlement to health services as
those with a medical card are more likely to be older,
less likely to be in good health and less likely to be work-
ing [8]. Clinical need was grouped into 1) chronic ill-
nesses targeted in the national immunisation guidelines
listed above [12], 2) other chronic conditions requiring
regular follow-up (arthritis, osteoporosis, cancer, psycho-
logical disorders, alcohol abuse, memory impairment,
stomach ulcers and varicose ulcers), 3) cardiovascular
risk factors (hypertension and high cholesterol), and (4)
no chronic illness. We also included other risk groups
recommended in the national guidelines for whom data
were available (morbid obesity and receipt of carers’ al-
lowance) [12]. Multicollinearity between covariates was
examined by calculating the mean and individual covariate
variance inflation factors (VIF). None of the individual co-
variate VIF were greater than 1.5 and the mean variance
inflation factors for all covariates included in the models
was 1.1. Interaction terms and stratified models were used
to investigate interaction between predictors. Adjusted
Population Attributable Fraction (PAF) estimates were
used to calculate the proportion of vaccination coverage
attributable to each level of entitlement to healthcare. The
results were weighted to reflect the complex sampling de-
sign and analyses were carried out using Stata 12.
Results
The mean age of the sample was 63.6 years (sd ± 9.3)
and 52.1% were female. Overall, 49.9% of the population
aged 50 years and over had received the vaccination in0%
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Figure 1 Vaccination rates across eligibility groups illustrating percenthe past (95% CI: 49-51%) (n = 4100). In terms of cover-
age for health services within the sample, 36.4% had a
medical card only (95% CI: 35-38%, n = 2621) and 16.1%
had both a medical card and private health insurance
(dual coverage) (95% CI: 15-17%, n = 1418).
Based on national guidelines, 68.6% of the population
were eligible for vaccination at the time of interview
(95% CI: 67-70%) (n = 5607) [12]. As Figure 1 illustrates
only 61.4% of that group were vaccinated (95% CI: 60-
63%) (n = 3441). Among the clinical risk group (those
with chronic conditions requiring continued follow-up
and excluding eligibility based on age), 68.6% were vacci-
nated (95% CI: 67-71%). Uptake in the clinical risk group
was much higher among those aged ≥65 compared to
those aged 50 to 64 years. Of those who did not meet
any of the ‘high-risk’ criteria, 17.2% (95% CI: 15-20%)
had received the vaccination in the past (n = 184).
Uptake rates within each of the at-risk groups varied
according to entitlement status, with higher vaccination
rates among medical card holders and those with dual
cover (Table 1). Vaccination rates among those with
chronic lung disease were 10% higher among medical
card holders (82%, 95% CI: 76-86%) compared to non-
medical card holders (71%, 95% CI: 60-79%). Of those
with congestive heart failure, 89% of those with a med-
ical card were vaccinated (95% CI: 78-95%) compared to
69% of those without a medical card (95% CI: 46-85%).
Table 2 presents the unadjusted and adjusted odds ra-
tios describing the relationship between socio-economic
enabling factors (medical card and private health insur-
ance status) and vaccination rates. Vaccination was sig-
nificantly associated with the level of entitlement to
health services: 63.2% of those with a medical card re-
ported being vaccinated (95% CI: 61-65%) compared tocal high risk
group
(2655)
50-64
(1163) (1492)
Clinical high risk group
tage uptake and 95% confidence intervals around estimates.
Table 1 Vaccination rates within each at-risk target group according to socio-economic enablers
Risk groupa Vaccinated
Medical Card only Dual cover Private Health Insurance only No additional cover
n % (95% CI)b n % (95% CI)b n % (95% CI)b n % (95% CI)b
Age ≥65 yearsc 1165 78.7 (76–81) 889 79.5 (77–82) 448 59.0 (55–63) 61 45.6 (37–55)
Chronic Heart Disease
Angina 195 80.3 (75–85) 98 85.7 (77–91) 43 54.0 (42–65) 6 37.0 (16–64)
Heart Attack 155 81.4 (75–86) 80 83.8 (74–90) 43 54.3 (43–65) 9 47.8 (27–69)
Congestive heart failure 35 90.3 (76–96) 23 86.6 (66–96) 12 71.4 (45–88) 3 61.8 (19–92)
Abnormal heart rhythm 169 76.5 (70–82) 116 77.5 (70–84) 102 54.3 (46–62) 11 32.1 (19–49)
Other heart trouble 80 78.8 (69–86) 62 79.9 (68–88) 61 59.2 (48–69) 8 40.8 (23–61)
Chronic lung disease
Chronic lung disease 131 79.1 (72–85) 60 88.1 (78–94) 51 71.5 (59–81) 18 68.2 (47–84)
Asthma 204 70.8 (65–76) 117 92.5 (86–96) 147 51.3 (45–58) 32 51.1 (38–64)
Diabetes 242 83.4 (78–87) 114 87.1 (80–92) 105 60.4 (53–68) 27 63.2 (47–77)
Chronic neurological disease
Parkinson’s disease 16 94.6 (68–99) 11 100 6 44.7 (16–77) 1 42.3 (49–91)
Stroke 52 73.0 (60–83) 28 67.9 (51–81) 9 42.5 (22–66) 1 39.0 (5–89)
TIA 68 81.7 (71–89) 37 91.2 (79–97) 24 55.6 (39–71) 2 25.6 (5–60)
Chronic liver disease 13 62.4 (40–81) 7 67.5 (35–89) 7 54.0 (25–80) 0 0
BMI ≥40 kg/m2 44 67.0 (54–78) 16 80.7 (56–93) 18 38.2 (25–53) 8 51.5 (28–74)
Carer (in receipt of state allowance) 36 46.6 (35–58) 11 58.9 (35–79) 4 26.0 (10–54) 3 20.3 (6–52)
No risk factor 124 29.1 (25–34) 68 40.3 (32–49) 402 24.2 (22–27) 65 17.4 (14–22)
Burden of Chronic Illness
None 157 41.3 (36–47) 92 50.5 (42–59) 174 20.4 (18–23) 36 13.3 (9–18)
High risk condition 835 75.6 (73–78) 481 83.1 (79–86) 425 52.2 (48–56) 86 45.3 (38–53)
Other Chronic illness 464 61.6 (58–65) 333 67.5 (63–72) 393 37.3 (34–41) 51 23.9 (18–31)
Cardiovascular risk factor 186 52.5 (47–58) 121 66.3 (58–74) 211 29.2 (26–33) 43 25.3 (19–33)
Fair/poor self-rated health 711 73.0 (70–76) 276 77.4 (73–82) 195 48.1 (43–53) 66 40.3 (33–48)
Total 1645 63.2 (61–65) 1030 71.6 (69–74) 1205 34.7 (33–37) 217 25.5 (22–29)
aGroups are not mutually exclusive as an individual may have more than 1 underlying health conditions listed. bPercentage estimates and confidence intervals adjusted
for sample design. cAt the time of data collection (2009), vaccination was typically recommended for those aged 65 and older. The national guidelines were updated in
2011 to include those aged 50 years and older.
Table 2 Association between socio-economic enablers and vaccination rates adjusted for demographic and need
factors
Entitlement to health
services
Vaccinated
N % (95% CI)a Unadj. 0R (95% CI) p value Adj. ORb (95% CI) p value PAF(95%CI)c
No additional cover 217 25.5% (22–29) 1 1
Medical card only 1645 63.2% (61–65) 5.0 (4.1-6.1) 0.000 2.0 (1.6-2.5) 0.000 0.08 (.05-.11)
Dual coverage 1030 71.6% (69–74) 7.4 (6.0-9.1) 0.000 2.2 (1.7-2.8) 0.000 0.05 (.03-.07)
Private Health Insurance only 1205 34.7% (33–37) 1.6 (1.3-1.9) 0.000 1.2 (1.0-1.5) 0.096 0.03 (−.01-.07)
aPercentage estimates and confidence intervals adjusted for sample design.
bModel adjusted for age (continuous) and sex, clinical need (including BMI > 40, carer status, guideline targeted chronic illness, other chronic illnesses,
cardiovascular risk), self-rated health and income tertiles.
cPopulation attributable fraction for vaccination rates based on OR adjusted for all other variables.
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card or private health insurance) (95% CI: 22-29%)
(Table 2). In multivariate analysis, having a medical card
was a significant independent predictor of vaccination,
controlling for age, sex, income, self-rated health and
clinical need (adjusted OR = 1.9, 95% CI: 1.5-2.5, p <
0.001). Having private health insurance only was not a
significant predictor of vaccination (OR = 1.2, 95% CI:
0.9-1.5, p = 0.194). Stratified analysis by age, income and
clinical need did not change the nature of the relation-
ship between entitlement to healthcare and receipt of flu
vaccination; having a medical card or dual coverage
remained a significant independent predictor of vaccin-
ation (results not reported). Adjusted Population Attrib-
utable Fraction (PAF) estimates indicated that 8% of
vaccination coverage was attributable to having a med-
ical card (95% CI: 5-11%) (Table 2).
Discussion
In this study, older people with a medical card were
twice as likely to be vaccinated against influenza, con-
trolling for age and clinical need. Uptake rates were con-
sistently higher among those with a medical card across
all risk groups. In our study, 74% of those aged 65 years
and older had received the flu vaccination in the past.
However, given that the study assessed having ever re-
ceived the flu vaccination, coverage in the most recent
campaign is likely to be much lower.
The results suggest that the partial public reimburse-
ment policy is leading to inequalities in vaccination
coverage among those with established clinical need rec-
ommended to receive the flu vaccination. The findings
suggest a step-like access to services in the Irish primary
care system; those on the lowest incomes qualify for free
access to services in general practice while those whose
incomes are just above the threshold for medical card
eligibility face difficulties accessing services, regardless of
clinical need. The results may also reflect the wider in-
fluence of medical card status on behaviour. Medical
card patients have significantly higher probability of vis-
iting their GP compared to those with private insurance,
even when differences in age and health status are con-
sidered [22]. A recent study estimated that people with a
medical card aged 70 years and over attended almost 10
times a year on average [23]. In this study, private health
insurance was not significantly associated with vaccin-
ation coverage illustrating the lack of additional benefit
conferred by private health insurance in terms of acces-
sing primary care services in Ireland.
Countries that reimburse healthcare practitioners for
administering the vaccine or those that provide vaccin-
ation within their public health insurance schemes tend
to have higher vaccination rates [6,24]. In Ireland, GPs
are paid a nominal fee by the Health Service Executivefor administering the vaccine to patients with a medical
card. Results from the European SHARE project indi-
cated that preventive service use was higher in health
systems where doctors were paid a fee-for-service, how-
ever the effect was not significant for flu vaccination [7].
Advice from health care professionals has a significant
impact on vaccination uptake [6,13,25,26], however it
was not possible to control for this and other physician
or system-related confounders in the analysis. Few stud-
ies have examined these factors which may contribute to
variability in flu vaccination rates. A recent study by
Blank et al. suggested an association between features of
European vaccination policies and coverage rates in the
elderly [27]. Countries which issued personal letters of-
fering free vaccination showed higher coverage rates.
This approach is not universally implemented in Ireland
[27] and the practice may be restricted to those with a
medical card who are easily identifiable within a practice
computer system. Other organisational interventions
shown to have a positive impact on vaccination rates in-
clude standing orders in the hospital or primary-care
settings, a patient mailing system [28], patient reminder
and recall systems in primary care settings [29] and pro-
viding the vaccination free of charge [30].
The association between age, chronic illness and vac-
cination coverage found in this study is well established
in previous research [6,7,13-15]. Within the clinical risk
group, we found that those in younger age group (50–
64) had lower vaccination coverage (53%) than those in
the older age group (81%) (≥65 years). While it could be
argued that the older group have a longer lead-in time
to ever have been vaccinated, there is evidence that age-
based immunisation policies are associated with higher
uptake among clinical risk groups than standard risk-
based policies. In a study of vaccination uptake among
clinical risk groups, Sammon et al. found that uptake
was higher among age groups where universal flu vac-
cination was recommended compared to age groups in
which only clinical groups were recommended for vac-
cination [5]. The Centers for Disease Control and Pre-
vention (CDC) suggest that this may be due to the
simpler health message attached to age-based policies,
eliminating the need for GPs to identify high risk indi-
viduals [31]. It is estimated that implementing a 100%
vaccination rate programme for all risk groups in the
five biggest European countries would require an add-
itional investment of €1.52 billion euro and would result
in estimated savings of €39.45 million from reduced pri-
mary care visits and further savings of €1.59 billion from
reduced hospitalisations [32]. The Irish government has
proposed the introduction of universal health insurance
including free primary care services. Plans to phase in
this reform by providing free GP care to those with
chronic illnesses in the first instance were replaced with
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Our study highlights some of the potential pitfalls of a
piecemeal approach to access based on income.
A nationally representative random sample partici-
pated in TILDA, based on stratified cluster sampling to
minimize selection bias [19]. The main limitation of this
study is the absence of information on the timing of vac-
cination, making it necessary to use having ever been
vaccinated as the outcome measure. Studies in other
countries examined coverage in the previous 12 months
[7,33] or the last vaccination campaign [14]. It was not
possible in this study to ascertain whether an individual
was entitled to a medical card or whether he/she was in
a high risk group at the time of vaccination. However,
past insurance status has been found to be a significant
predictor of current insurance status in Ireland [34].
Similarly, several studies have demonstrated the positive
impact possession of a medical card has on GP use in
Ireland [22,35]. While we cannot assert definitively that
possession of a medical card now will increase the likeli-
hood of vaccination now, the observed persistence in in-
surance status and numerous studies detailing the
relationship between current medical card status and
current GP use strongly indicate that this is a reasonable
inference to draw from these results. This paper has im-
portant policy implications as it highlights the weak-
nesses of a health system where access to services is
based on income rather than need. The pattern detected
in this study endures after adjustment for age, income
and clinical need.
Self-reported vaccination was above 70% for those
with a medical card in high risk clinical groups, although
this rate varied between illness groups. While a self-
reported outcome measure is open to recall bias, studies
have found high sensitivity and a high level of agreement
between medical records and self-reported vaccination
[36,37]. It was not possible to account for all high risk
groups in the dataset, for example data were not re-
corded on renal disease and identification of carers was
based on receipt of state allowance, which represents
only a minority of carers in Ireland [38].
Conclusions
In our study, having a medical card significantly in-
creased the likelihood of having received the flu vaccine,
independent of clinical need. This suggests that having
free access is a stronger driver of uptake than clinical
need. The mismatch between vaccination guidelines and
reimbursement policy is creating gaps in coverage and
unequal access to recommended services for high risk
groups.
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